As of Jun 24
| -0.10 / -5.24%|
The 3 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 1.50. The median estimate represents a +93.37% increase from the last price of 1.81.
The current consensus among 7 polled investment analysts is to Hold stock in Arena Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.